Product: succinylcholine 200 mg/10 mL (20 mg/mL), Syringe, Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue Pheonix, AZ, NDC 72196-6011-2.
Reason for recall: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated: 20230714
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated